Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cardiff Oncology Inc. sell goldmanns

Start price
€4.51
18.03.24 / 0%
Target price
-
18.03.25
Performance (%)
-20.51%
End price
€3.59
19.03.25
Summary
This prediction ended on 19.03.25 with a price of €3.59. The prediction for Cardiff Oncology Inc. closed with a convincing performance of -20.51%. This prediction was marked as speculative and is excluded from goldmanns's performance statistics.
Performance without dividends (%)
Name 1w 1m 1y
Cardiff Oncology Inc. 9.677% 9.677% -34.510%
iShares Core DAX® 0.734% -0.964% 17.910%
iShares Nasdaq 100 -2.686% -2.409% 4.267%
iShares Nikkei 225® -2.261% -4.038% 10.420%
iShares S&P 500 -1.346% -1.510% 1.615%

Comments by goldmanns for this prediction

In the thread Trovagene diskutieren

Sell Cardiff Oncology Inc.

In the thread Trading Trovagene
Prediction Sell
Perf. (%) -20.51%
Target price
Change
Ends at 18.03.25

Die von goldmanns gewählte maximale Laufzeit wurde überschritten